We are live on
!
Find out more
LCM
LVM Capital Management Portfolio holdings
AUM
$1.19B
1-Year Est. Return
41.5%
This Fund
S&P 500
This Quarter
Est. Return
+2.18%
1 Year Est. Return
+41.5%
3 Year Est. Return
+106.81%
5 Year Est. Return
+141.04%
10 Year Est. Return
+408.04%
AUM
$392M
AUM Growth
+$3.02M
(+0.78%)
Cap. Flow
-$3.45M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
45%
Holding
122
New
6
Increased
46
Reduced
38
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$6.4M |
| 2 |
Morgan Stanley
MS
|
+$5.04M |
| 3 |
NYRT
New York REIT, Inc.
NYRT
|
+$1.95M |
| 4 |
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
|
+$647K |
| 5 |
Amgen
AMGN
|
+$623K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCG
Scana
SCG
|
+$10.2M |
| 2 |
Target
TGT
|
+$3.8M |
| 3 |
Philip Morris
PM
|
+$463K |
| 4 |
DFT
DuPont Fabros Technology Inc.
DFT
|
+$412K |
| 5 |
Walmart Inc
WMT
|
+$346K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.55% |
| 2 | Technology | 18.24% |
| 3 | Industrials | 13.29% |
| 4 | Communication Services | 10.45% |
| 5 | Financials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
101
DELISTED
Walgreens Boots Alliance
WBA
| $245K | 0.06% |
3,125
| – | – |
|
102
Colgate-Palmolive
CL
$73.1B
| $237K | 0.06% |
3,200
| – | – |
|
103
Enbridge
ENB
$119B
| $227K | 0.06% |
5,693
+492
| +9% | +$19.8K |
|
104
Kimberly-Clark
KMB
$36.3B
| $223K | 0.06% |
1,725
-100
| -5% | -$13K |
|
105
US Bancorp
USB
$98.2B
| $223K | 0.06% |
4,300
| – | – |
|
106
Bank of America
BAC
$435B
| $214K | 0.05% |
8,801
-1,666
| -16% | -$38.8K |
|
107
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $211K | 0.05% |
5,928
| – | – |
|
108
Vanguard Dividend Appreciation ETF
VIG
$111B
| $208K | 0.05% |
2,248
+4
| +0.2% | +$367 |
|
109
General Dynamics
GD
$104B
| $206K | 0.05% |
+1,040
| New | +$204K |
|
110
PACCAR
PCAR
$69.8B
| $202K | 0.05% |
4,593
| – | – |
|
111
TotalEnergies
TTE
$195B
| $202K | 0.05% |
4,075
| – | – |
|
112
Gentex
GNTX
$4.97B
| $194K | 0.05% |
+10,225
| New | +$199K |
|
|
CBAY
113
DELISTED
Cymabay Therapeutics
CBAY
| $115K | 0.03% |
20,000
+10,000
| +100% | +$42.6K |
|
|
MMAT
114
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $17K | ﹤0.01% |
+50
| New | +$14.6K |
|
115
Incyte
INCY
$24.2B
| – | – |
-2,000
| Closed | -$267K |
|
116
Reinsurance Group of America
RGA
$15.5B
| – | – |
-1,867
| Closed | -$237K |
|
|
117
Target
TGT
$65.6B
| – | – |
-68,780
| Closed | -$3.8M |
|
|
118
Walmart Inc
WMT
$885B
| – | – |
-14,400
| Closed | -$346K |
|
Similar funds
KOC
CCM
SC
CA
SCM
AIM
MMFA
EC
LVM Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, LVM Capital Management held 122 positions worth $392M, up 0.78% from $389M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
LVM Capital Management's Q2 2017 filing shows 6 new, 46 increased, 38 reduced and 5 closed positions. Its largest new stake was New York REIT, Inc.: 21,513 shares worth $1.86M. The largest sale was Scana, an estimated $10.2M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- LVM Capital Management's largest Q2 2017 buy was New York REIT, Inc.: 21,513 shares worth $1.86M.
- LVM Capital Management added most to NXP Semiconductors in Q2 2017, an estimated $6.4M increase.
- LVM Capital Management's biggest Q2 2017 reduction was Scana, cutting an estimated $10.2M.
- LVM Capital Management fully exited Target in Q2 2017, selling an estimated $3.8M.
- LVM Capital Management's ten largest holdings make up 45% of its $392M portfolio in Q2 2017.
- LVM Capital Management opened 6 new positions and closed 5 in Q2 2017.
- LVM Capital Management's portfolio value rose 0.78% quarter-over-quarter to $392M.
Based on LVM Capital Management's 13F filing for Q2 2017, filed 14 Jul 2017.